Amgen Inc. (NASDAQ:AMGN ) Goldman Sachs 43rd Annual Global Healthcare Conference June 15, 2022 4:40 PM ET Company Participants Peter Griffith - Executive Vice President, Chief Financial Officer Dave R
Amgen's Lumakras revenue is ramping rapidly. Amgen Phase 2 topline olpasiran data was positive.

2 Best Biotech Stocks to Buy Right Now

10:53am, Saturday, 11'th Jun 2022
These two pharma stocks boast 3%-plus dividend yields, double the S&P 500 index's 1.5% dividend yield.

7 Dividend Stocks to Buy for Your Grandkids

06:43am, Saturday, 11'th Jun 2022
If this roiling market is making you seasick, then it's an excellent time batten down the hatches with these reliable dividend stocks. The post 7 Dividend Stocks to Buy for Your Grandkids appeared fir
THOUSAND OAKS, Calif. , June 10, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 43rd Annual Healthcare Conference at 1:40 p.m.
Amgen Inc. (NASDAQ:AMGN ) 2022 Jefferies Global Healthcare Conference June 8, 2022 9:30 AM ET Company Participants Arvind Sood - Vice President, Investor Relations Murdo Gordon - Executive Vice Presid
Without a doubt, 2022 has been one of the worst years for stock investors in some time.
The market could be on the verge of going a lot higher. Many high-quality stocks are still trading at bargain prices.

3 of the Best Ways to Invest for Retirement

05:19am, Thursday, 02'nd Jun 2022
It's never too early to plan for the golden years, and if you started late you can still take advantage of opportunities.
Amgen's (AMGN) olpasiran, a small interfering RNA molecule, is designed in such a way that it lowers the body's production of apolipoprotein(a), a key component of Lp(a) which increases the risk of ca
Blue-chip name Amgen, Inc.  (NASDAQ:AMGN) earlier reported its olpasiran therapy helped reduce cholesterol levels in patients with atherosclerotic cardiovascular disease (ASCVD), according to topli
Could these biotech stocks be worth watching in the stock market today?

Mirati (MRTX) Down 23% on Mixed Data From Lung Cancer Study

06:39pm, Friday, 27'th May 2022 Zacks Investment Research
Mirati (MRTX) posts positive data from a phase II study evaluating its lung cancer candidate adagrasib. However, the drug caused side-effects in a large number of study participants.

Amgen (AMGN) Up 6.3% Since Last Earnings Report: Can It Continue?

04:11pm, Friday, 27'th May 2022 Zacks Investment Research
Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

3 Reasons to Buy and Hold This Dividend Stock

02:00pm, Friday, 27'th May 2022 The Motley Fool
Amgen's 3.1% dividend yield is nearly double the S&P 500's -- and that's not the only thing to like about the stock.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE